|
1
|
Calabrese V, Santoro A, Monti D, Crupi R,
Di Paola R, Latteri S, Cuzzocrea S, Zappia M, Giordano J, Calabrese
EJ and Franceschi C: Aging and Parkinson's Disease: Inflammaging,
neuroinflammation and biological remodeling as key factors in
pathogenesis. Free Radic Biol Med. 115:80–91. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Feng P, Zhang X, Li D, Ji C, Yuan Z, Wang
R, Xue G, Li G and Hölscher C: Two novel dual GLP-1/GIP receptor
agonists are neuroprotective in the MPTP mouse model of Parkinson's
disease. Neuropharmacology. 133:385–394. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chinta SJ, Woods G, Demaria M, Rane A, Zou
Y, McQuade A, Rajagopalan S, Limbad C, Madden DT, Campisi J and
Andersen JK: Cellular senescence is induced by the environmental
neurotoxin paraquat and contributes to neuropathology linked to
Parkinson's disease. Cell Rep. 22:930–940. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Castelo-Branco G, Wagner J, Rodriguez FJ,
Kele J, Sousa K, Rawal N, Pasolli HA, Fuchs E, Kitajewski J and
Arenas E: Differential regulation of midbrain dopaminergic neuron
development by Wnt-1, Wnt-3a, and Wnt-5a. Proc Natl Acad Sci USA.
100:12747–12752. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
De Gregorio R, Pulcrano S, De Sanctis C,
Volpicelli F, Guatteo E, von Oerthel L, Latagliata EC, Esposito R,
Piscitelli RM, Perrone-Capano C, et al: miR-34b/c regulates Wnt1
and enhances mesencephalic dopaminergic neuron differentiation.
Stem Cell Reports. 10:1237–1250. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Blakely BD, Bye CR, Fernando CV, Horne MK,
Macheda ML, Stacker SA, Arenas E and Parish CL: Wnt5a regulates
midbrain dopaminergic axon growth and guidance. PLoS One.
6:e183732011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kitagawa H, Ray W, Glantschnig H,
Nantermet P, Yu Y, Leu CS, Kato S and Freedman L: A regulatory
circuit mediating convergence between Nurr1 transcriptional
regulation and Wnt signaling. Mol Cell Biol. 34:9172014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Andersson ER, Saltó C, Villaescusa JC,
Cajanek L, Yang S, Bryjova L, Nagy II, Vainio SJ, Ramirez C, Bryja
V and Arenas E: Wnt5a cooperates with canonical Wnts to generate
midbrain dopaminergic neurons in vivo and in stem cells. Proc Natl
Acad Sci USA. 110:E602–E610. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li HY, Liu F and Wang HR: Correlation
between Nurr1 expression and drug resistance in the brain of rats
with epilepsy. Eur Rev Med Pharmacol Sci. 22:1506–1513.
2018.PubMed/NCBI
|
|
10
|
Chen XX, Qian Y, Wang XP, Tang ZW, Xu JT,
Lin H, Yang ZY, Song XB, Lu D, Guo JZ, et al: Nurr1 promotes
neurogenesis of dopaminergic neuron and represses inflammatory
factors in the transwell coculture system of neural stem cells and
microglia. CNS Neurosci Ther. 24:790–800. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nagatsu T and Nagatsu I: Tyrosine
hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other
catecholamine-related enzymes, and their human genes in relation to
the drug and gene therapies of Parkinson's disease (PD): Historical
overview and future prospects. J Neural Transm. 123:1255–1278.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim KS, Kim CH, Hwang DY, Seo H, Chung S,
Hong SJ, Lim JK, Anderson T and Isacson O: Orphan nuclear receptor
Nurr1 directly transactivates the promoter activity of the tyrosine
hydroxylase gene in a cell-specific manner. J Neurochem.
85:622–634. 2010. View Article : Google Scholar
|
|
13
|
Ding Y, Zhang Z, Ma J, Xia H, Wang Y, Liu
Y, Ma Q, Sun T and Liu J: Directed differentiation of postnatal
hippocampal neural stem cells generates nuclear receptor related-1
protein- and tyrosine hydroxylase-expressing cells. Mol Med Rep.
14:1993–1999. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma J, Huang C, Ma K, Wu YP, Li BX and Sun
Y: Effect of Wnt1 and Wnt5a on the development of dopaminergic
neurons, and toxicity induced by combined exposure to paraquat and
maneb during gestation and lactation. Mol Med Rep. 16:9721–9728.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tinakoua A, Bouabid S, Faggiani E, De
Deurwaerdere P, Lakhdar-Ghazal N and Benazzouz A: The impact of
combined administration of paraquat and maneb on motor and
non-motor functions in the rat. Neuroscience. 311:118–129. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bastias-Candia S, Di Benedetto M,
D'Addario C, Candeletti S and Romualdi P: Combined exposure to
agriculture pesticides, paraquat and maneb, induces alterations in
the N/OFQ-NOPr and PDYN/KOPr systems in rats: Relevance to sporadic
Parkinson's disease. Environ Toxicol. 30:656–663. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Desplats P, Patel P, Kosberg K, Mante M,
Patrick C, Rockenstein E, Fujita M, Hashimoto M and Masliah E:
Combined exposure to maneb and paraquat alters transcriptional
regulation of neurogenesis-related genes in mice models of
Parkinson's disease. Mol Neurodegener. 7:492012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gupta SP, Patel S, Yadav S, Singh AK,
Singh S and Singh MP: Involvement of nitric oxide in maneb- and
paraquat-induced Parkinson's disease phenotype in mouse: Is there
any link with lipid peroxidation? Neurochem Res. 35:1206–1213.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kovalevich J and Langford D:
Considerations for the use of SH-SY5Y neuroblastoma cells in
neurobiology. Methods Mol Biol. 1078:9–21. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu T, Niu C, Zhang X and Dong M:
β-Ecdysterone protects SH-SY5Y cells against β-amyloid-induced
apoptosis via c-Jun N-terminal kinase- and Akt-associated
complementary pathways. Lab Invest. 98:489–499. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Song Y, Liu Y and Chen X: MiR-212
attenuates MPP+-induced neuronal damage by targeting
KLF4 in SH-SY5Y cells. Yonsei Med J. 59:416–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang CY, Sun ZN, Wang MX and Zhang C:
SIRT1 mediates salidroside-elicited protective effects against
MPP+-induced apoptosis and oxidative stress in SH-SY5Y
cells: Involvement in suppressing MAPK pathways. Cell Biol Int.
42:842018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Presgraves SP, Borwege S, Millan MJ and
Joyce JN: Involvement of dopamine D(2)/D(3) receptors and BDNF in
the neuroprotective effects of S32504 and pramipexole against
1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y
cells. Exp Neurol. 190:157–170. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roede JR, Hansen JM, Go YM and Jones DP:
Maneb and paraquat-mediated neurotoxicity: Involvement of
peroxiredoxin/thioredoxin system. Toxicol Sci. 121:368–375. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Caputi FF, Carretta D, Lattanzio F,
Palmisano M, Candeletti S and Romualdi P: Proteasome subunit and
opioid receptor gene expression down-regulation induced by paraquat
and maneb in human neuroblastoma SH-SY5Y cells. Environ Toxicol
Pharmacol. 40:895–900. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tang MZ and Huang EJ: β-Catenin controls
neurogenesis of midbrain dopamine neurons through cell adhesion and
junctional complex formation. Int J Dev Neurosci. 26:886. 2008.
View Article : Google Scholar
|
|
27
|
Colini Baldeschi A, Pittaluga E, Andreola
F, Rossi S, Cozzolino M, Nicotera G, Sferrazza G, Pierimarchi P and
Serafino A: Atrial natriuretic peptide acts as a neuroprotective
agent in in vitro models of Parkinson's disease via Up-regulation
of the Wnt/β-catenin pathway. Front Aging Neurosci. 10:202018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Davis SW, Mortensen AH, Keisler JL,
Zacharias AL, Gage PJ, Yamamura K and Campe SA: β-catenin is
required in the neural crest and mesencephalon for pituitary gland
organogenesis. BMC Dev Biol. 16:162016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Diaz-Ruiz O, Zhang Y, Shan L, Malik N,
Hoffman AF, Ladenheim B, Cadet JL, Lupica CR, Tagliaferro A, Brusco
A and Bäckman CM: Attenuated response to methamphetamine
sensitization and deficits in motor learning and memory after
selective deletion of β-catenin in dopamine neurons. Learn Mem.
19:341–350. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang L, Luan C, Qu S, Lei W, Mo M, Feng
J, Sun C, Xiao Y, Qin L, Li S, et al: Enhancing beta-catenin
activity via GSK3beta inhibition protects PC12 cells against
rotenone toxicity through Nurr1 induction. PLoS One.
11:e01529312016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Smits SM, Ponnio T, Conneely OM, Burbach
JP and Smidt MP: Involvement of Nurr1 in specifying the
neurotransmitter identity of ventral midbrain dopaminergic neurons.
Eur J Neurosci. 18:1731–1738. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ahn JH, Lee JS, Cho JH, Park JH, Lee TK,
Song M, Kim H, Kang SH, Won MH and Lee CH: Age-dependent decrease
of Nurr1 protein expression in the gerbil hippocampus. Biomed Rep.
8:517–522. 2018.PubMed/NCBI
|
|
33
|
Dong J, Wang Y, Liu XY and Le WD: Nurr1
deficiency-mediated inflammatory injury to nigral dopamine neurons
in Parkinson's disease. Parkinsonism Relat Disord. 46:e662018.
View Article : Google Scholar
|
|
34
|
Kummari E, Guo-Ross S and Eells JB: Region
specific effects of aging and the Nurr1-Null heterozygous genotype
on dopamine neurotransmission. Neurochem Neuropharmacol. 3(pii):
1142017.PubMed/NCBI
|
|
35
|
Le W, Pan T, Huang M, Xu P, Xie W, Zhu W,
Zhang X, Deng H and Jankovic J: Decreased NURR1 gene expression in
patients with Parkinson's disease. J Neurol Sci. 273:29–33. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sakurada K, Ohshima-Sakurada M, Palmer TD
and Gage FH: Nurr1, an orphan nuclear receptor, is a
transcriptional activator of endogenous tyrosine hydroxylase in
neural progenitor cells derived from the adult brain. Development.
126:4017–4026. 1999.PubMed/NCBI
|
|
37
|
Parish CL, Castelo-Branco G, Rawal N,
Tonnesen J, Sorensen AT, Salto C, Kokaia M, Lindvall O and Arenas
E: Wnt5a-treated midbrain neural stem cells improve dopamine cell
replacement therapy in parkinsonian mice. J Clin Invest.
118:149–160. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bisson JA, Mills B, Paul Helt JC, Zwaka TP
and Cohen ED: Wnt5a and Wnt11 inhibit the canonical Wnt pathway and
promote cardiac progenitor development via the Caspase-dependent
degradation of AKT. Dev Biol. 398:80–96. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Panhuysen M, Vogt Weisenhorn DM, Blanquet
V, Brodski C, Heinzmann U, Beisker W and Wurst W: Effects of Wnt1
signaling on proliferation in the developing mid-/hindbrain region.
Mol Cell Neurosci. 26:101–111. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Andersson ER, Prakash N, Cajanek L, Minina
E, Bryja V, Bryjova L, Yamaguchi TP, Hall AC, Wurst W and Arenas E:
Wnt5a regulates ventral midbrain morphogenesis and the development
of A9-A10 dopaminergic cells in vivo. PLoS One. 3:e35172008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Joksimovic M and Awatramani R:
Wnt/β-catenin signaling in midbrain dopaminergic neuron
specification and neurogenesis. J Mol Cell Biol. 6:27–33. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Prakash N and Wurst W: Development of
dopaminergic neurons in the mammalian brain. Cell Mol Life Sci.
63:187–206. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Alves dos Santos MT and Smidt MP: En1 and
Wnt signaling in midbrain dopaminergic neuronal development. Neural
Dev. 6:232011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wei L, Sun C, Lei M, Li G, Yi L, Luo F, Li
Y, Ding L, Liu Z, Li S and Xu P: Activation of Wnt/β-catenin
pathway by exogenous Wnt1 Protects SH-SY5Y cells against
6-hydroxydopamine toxicity. J Mol Neurosci. 49:105–115. 2013.
View Article : Google Scholar : PubMed/NCBI
|
